Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

MedCity and the KPBMA on the Evolution of Immuno-Oncology Webinar

Thursday, 17 September 2020, 8.30am to 10am

MedCity and the KPBMA (Korean Pharmaceutical and BioPharma Manufacturers Association) will be hosting a joint webinar in mid-September on the Evolution of Immuno-Oncology.

MedCity and the KPBMA (Korean Pharmaceutical and BioPharma Manufacturers Association) will be hosting a joint webinar in mid-September on the Evolution of Immuno-Oncology. High profile speakers from the UK and Korea will be sharing their insights during this international collaborative event.

Further details coming shortly on speakers, final agenda, this event is open to all those working in advanced therapies. To find out more about joining the advanced therapies network please contact us or go to https://www.medcityhq.com/advanced-therapies-network/

The Advanced Therapies Network (ATN) aims to support networking opportunities and knowledge exchange between academic organisations, life sciences companies and investors in this area.